We are a pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs.
Our principal office in Asia provides easy access to prosperous medical research resources and some of the world’s most talented specialists and clinicians. We have established strong relationships and collaborations with leading academic institutions to propel therapeutic innovations.
To date, Aptorum has obtained 12 exclusively licensed technologies in the areas of neurology, infectious diseases, gastroenterology, oncology, surgical robotics and natural health.
Source
